Yesilöz, U., Kirches, E., Hartmann, C., Scholz, J., Kropf, S., Sahm, F., . . . Mawrin, C. (2017). Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Neuro-Oncology, 19(8), . https://doi.org/10.1093/neuonc/nox018
Chicago-Zitierstil (17. Ausg.)Yesilöz, Ümmügülsüm, Elmar Kirches, Christian Hartmann, Johannes Scholz, Siegfried Kropf, Felix Sahm, Makoto Nakamura, und Christian Mawrin. "Frequent AKT1E17K Mutations in Skull Base Meningiomas Are Associated with MTOR and ERK1/2 Activation and Reduced Time to Tumor Recurrence." Neuro-Oncology 19, no. 8 (2017). https://doi.org/10.1093/neuonc/nox018.
MLA-Zitierstil (9. Ausg.)Yesilöz, Ümmügülsüm, et al. "Frequent AKT1E17K Mutations in Skull Base Meningiomas Are Associated with MTOR and ERK1/2 Activation and Reduced Time to Tumor Recurrence." Neuro-Oncology, vol. 19, no. 8, 2017, https://doi.org/10.1093/neuonc/nox018.